What if one of the keys to healthier aging lies in eliminating cells that refuse to die?

As we grow older, certain cells enter a state called cellular senescence. They stop dividing but remain alive, sometimes releasing inflammatory signals that disrupt surrounding tissues and contribute to age-related deterioration.

Scientists are investigating an intriguing possibility: could selectively removing these cells slow certain aspects of biological decline?

In Episode 7 of the Metanthropy Podcast, Max Nova explores the emerging science of senolytics—experimental interventions designed to eliminate specific populations of senescent cells.

We investigate how cellular senescence works, why it can both protect and harm the body, and what researchers have discovered about compounds such as dasatinib, quercetin, and fisetin. From remarkable experiments in mice to human clinical trials—including promising new findings in liver disease—we examine the evidence, the limitations, and the unanswered questions.

Can senolytics genuinely improve human healthspan? Could they eventually become part of a new generation of therapies targeting biological aging? Or are we still overlooking crucial complexities?

The science is fascinating. The possibilities are enormous. But the distance between a promising mechanism and a proven anti-aging treatment remains substantial.

Metanthropy explores the future of the human condition through science, emerging technologies, transhumanism, and compassionate self-directed evolution.

Humanity is precious, but not final.

Why can today’s AI write code, translate languages, and reason about complex problems—yet a robot can still struggle to pick up a glass, fold a towel, or tidy a kitchen?

In Episode 6 of the Metanthropy Podcast, Max Nova explores the strange difficulty of embodied intelligence: the gap between understanding the physical world and acting reliably inside it.

We examine robotic perception, grasp planning, tactile sensing, force control, deformable objects, imitation learning, simulation, generalization, long-horizon tasks, and physical safety. Along the way, we look at why human abilities that feel effortless are extraordinarily difficult to reproduce in machines—and why impressive robot demonstrations do not necessarily translate into reliable everyday usefulness.

The deeper question is not whether robots can perform isolated tasks. It is whether artificial intelligence can become physically competent enough to operate safely and adaptively in the messy, unpredictable environments humans inhabit.

Because the next frontier of AI may not be thinking better.

It may be learning how to touch the world.

Metanthropy explores the future of the human condition through science, technology, transhumanism, philosophy, and compassionate self-directed evolution.

Artificial intelligence is beginning to do more than analyze biological data. It is learning patterns across DNA, RNA, proteins, genomes and cellular behavior — then using those patterns to predict structures, generate new molecules and propose biological designs that may never have existed in nature.

In this episode of Metanthropy, Max Nova explores the rapidly emerging field of generative biology: from AlphaFold and protein language models to genomic AI, virtual cells, AI-designed proteins and synthetic phage genomes.

What does it really mean to say that AI is learning “the language of life”? How do biological foundation models work? Where does the analogy with human language break down? And how close are we to moving from reading biology to deliberately writing it?

This is not a story about machines replacing scientists. It is about a new scientific instrument capable of compressing evolutionary information, navigating enormous biological design spaces and accelerating the cycle between hypothesis, experiment and correction.

The age of computational biology is becoming the age of generative biology.

AI is learning to read the archive of evolution — and the first artificial sentences are beginning to live.